Integrated pan-cancer analysis and experimental validation reveal that syndecan-1 drives glioblastoma pathogenesis and associates with immune infiltration. - Wang Q; Ai W; Yu S; Xu Y; Lei K; Lv S (Discover oncology, 2026)